Crohn’s Disease Researcher Raja Atreya Awarded Paul Ehrlich and Ludwig Darmstaedter Prize

Crohn’s Disease Researcher Raja Atreya Awarded Paul Ehrlich and Ludwig Darmstaedter Prize
The 2015 €60,000 Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers has been awarded to Professor Raja Atreya from Medical Clinic 1 of the Erlangen University Hospital who has developed a novel diagnostic device that indicates whether patients with Crohn's disease will benefit from treatment with a TNF antagonist or not.   Dr. Atreya was appointed W1 Assistant Professor at the institution at Erlangen, near Nuremberg in south-central Germany in 2010 and has headed the outpatient care unit for clinical studies since 2012. In 2013 he completed his examinations as a specialist in internal medicine, and is now a Senior Resident heading the hospital's Inflammatory Bowel Disease unit as well as outpatient care for the university and clinical trials.   Using Dr. Atreya's innovative diagnostic method, physicians can predict clinical response to an expensive treatment for Crohn's disease that has been associated with potential negative side effects including a possible increased risk of cancer, risk of infections and allergies and possible defensive reactions. This treatment addressing TNF antagonists is effective in only about 50 percent of patients, while the other 50 percent other patients experience the risks of side effects of the drug without accruing any clinical benefit from the therapy. Pauskiirceh2015 Photo Caption: James Allison, a biologist and professor of immunolog
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *